화학DB 개요  |  화학제품[Product]  |  화학물질[Chemical]  |  화학업체[Company]
Nanjing CHICO pharmaceutical Co.,Ltd.
제조
No.9 Weidi Road-Jiangsu Life Science an d Technology Innovation Park,Nanjing ,Jiangsu, China
86-025-84351676
86-025-52261140
CHINA
Laura Liu
info@chicopharm.com
www.chicopharm.com
업체관련분야 의약,중간체
회사소개

Nanjing CHICO pharmaceutical Co.,Ltd. is a high-tech enterprise engaged in synthesis of pharmaceutical raw materials and pharmaceutical intermediates, serving global pharmaceutical industry with best quality products , professional services and on-time delivery.
We supply APIs and intermediates in both bulk industry scale and R&D laboratory scale. We have a R&D center in Nanjing with a well experienced R&D team, leaded by lots of pharmaceutical and chemical experts and professors which closely following the international new drug research and development dynamic that help us to provide a strong continuous innovation, and make us always stand in the forefront of new drug research and development. We form a targeted anti-tumor, anticoagulant, anti-diabetes medicine raw materials and intermediate products system.

현화학업체가 제조하는 화학제품 목록
5-Bromo-2-chlorobenzoic acid  -  Dapagliflozin intermediates
Apixaban  -  Apixaban Cardiovasculars
Aripiprazole  -  Aripiprazole Anti-Psychotic
Saxagliptin hydrate  -  Saxagliptin anti-diabetics
Tenofovir disoproxil fumarate  -  Tenofovir HIV
(1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium  -  Ticagrelor intermediates
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester  -  Saxagliptin intermediates
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile  -  Vildagliptin intermediates
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester  -  Teneligliptin intermediates
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine  -  Sitagliptin intermediates
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one  -  Sitagliptin intermediates
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan  -  Empagliflozin intermediates
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan  -  Empagliflozin intermediates
(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone  -  Dapagliflozin intermediates
(R)-3-(Boc-Amino)piperidine  -  Alogliptin intermediates
(R)-3-Aminopiperidine dihydrochloride  -  Alogliptin intermediates
(R)-4-(5-chlorobenzo[d]oxazol-2-yl)-7-Methyl-1,4-diazepan-1-iuM (2S,3S)-2,3-bis(benzoyloxy)-3-carboxypropanoate  -  Suvorexant Intermediates
(S)-(+)-N-(2,3-Epoxypropyl)phthalimide  -  Rivaroxaban intermediates
(S)-3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine, N-acetyl-glutarate  -  Repaglinide intermediates
1-(2,3-Dichlorophenyl)piperazine hydrochloride  -  Aripiprazole intermediates
1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine  -  Teneligliptin intermediates
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4);5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride (1:4)  -  Daclatasvir Intermediates
1-Pyrrolidinecarboxylic acid, 2,2'-([1,1'-biphenyl]-4,4'-diyldi-1H-iMidazole-5,2-diyl)bis-, 1,1'-bis(1,1-diMethylethyl) ester, (2S,2'S)-  -  Daclatasvir Intermediates
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid  -  Ticagrelor intermediates
2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID  -  Suvorexant Intermediates
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene  -  Canagliflozin intermediates
2-(4-Fluorophenyl)thiophene  -  Canagliflozin intermediates
2-(Chloromethyl)-4-methylquinazoline  -  Linagliptin intermediates
2,5-Dichlorobenzooxazole  -  Suvorexant Intermediates
2-[(5-Bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene  -  Canagliflozin intermediates
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyrimidinyl)Methyl]  -  Alogliptin intermediates
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone  -  Prasugrel intermediates
2-Cyano-5-fluorobenzyl bromide  -  Trelagliptin intermediate
2-Cyanobenzyl bromide  -  Alogliptin intermediates
2-oxo-2,4,5,6,7,7a-hexahydrothieno [3, 2-c] pyridine. Hydrochloride  -  Prasugrel intermediates
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride  -  Sitagliptin intermediates
3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone  -  Aripiprazole intermediates
3-amino-1-adamantanol  -  Vildagliptin intermediates
3-Ethoxy-4-ethoxycarbonyl phenylacetic acid  -  Repaglinide intermediates
4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate)  -  Suvorexant Intermediates
4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate)  -  Suvorexant Intermediates
4-((2-aMinoethyl)(5-chlorobenzo[d]oxazol-2-yl)aMino)butan-2-one (diMethanesulfonate)  -  Suvorexant Intermediates
4-(4-Aminophenyl)morpholin-3-one  -  Rivaroxaban intermediates
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether  -  Dapagliflozin intermediates
4,5,6,7-Tetrahydrothieno[3,2,c] pyridine hydrochloride  -  Prasugrel intermediates
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine  -  Ticagrelor intermediates
5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone  -  Apixaban intermediates
5-Chlorobenzooxazole-2-thiol  -  Suvorexant Intermediates
5-Chlorothiophene-2-carboxylic acid  -  Rivaroxaban intermediates
5-Iodo-2-methylbenzoic acid  -  Canagliflozin intermediates
6-Chloro-3-methyluracil  -  Alogliptin intermediates
7-hydroxy-3,4-Dihydro-2(1H)-quinolinone  -  Aripiprazole intermediates
8-Bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione  -  Linagliptin intermediates
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione  -  Linagliptin intermediates
Alogliptin Benzoate  -  Alogliptin INN anti-diabetics
Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid  -  Sitagliptin intermediates
Boc-3-Hydroxy-1-adamantyl-D-glycine  -  Saxagliptin intermediates
Canagliflozin hemihydrate  -  Canagliflozin anti-diabetics SGLT2 inhibitors
Cyclopropyl 2-fluorobenzyl ketone  -  Prasugrel intermediates
Dabigatran etexilate  -  Dabigatran Cardiovasculars
Daclatasvir (BMS-790052)  -  API for HCV
Dapagliflozin  -  Dapagliflozin anti-diabetics SGLT2 inhibitors
Diethyl (tosyloxy)methylphosphonate  -  Tenofovir intermediates
Endo-3-amine-9-methyl-9-azabicyclo[3,3,1]nonane  -  intermediate
ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate  -  Apixaban intermediates
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate  -  Apixaban intermediates
lifenacin succinate  -  API
Linagliptin  -  Linagliptin anti-diabetics
L-Prolinamide  -  Vildagliptin intermediates
Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate  -  Sitagliptin intermediates
Picolinic acid  -  Fine Chemicals
Prasugrel  -  Prasugrel Cardiovasculars
R-(+)-9-(2-Hydroxypropyl)adenine  -  Tenofovir intermediates
Repaglinide  -  Repaglinide anti-diabetics
Riociguat  -  api
Rivaroxaban  -  Rivaroxaban Cardiovasculars
Sitagliptin phosphate monohydrate  -  Sitagliptin INN anti-diabetics
Sofosbuvir  -  API for HCV
Suvorexant (MK-4305)  -  API for nervous system
Teneligliptin HBr  -  Teneligliptin anti-diabetics
Ticagrelor  -  Ticagrelor Cardiovasculars
Trelagliptin succinate  -  Trelagliptin anti-diabetics
Vildagliptin  -  vildagliptin INN anti-diabetics

현화학업체가 제조 또는 판매하는 화학물질 목록
현화학업체로 등록된 화학물질이 없습니다!